These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Schlosshauer PW, Ellenson LH, Soslow RA. Mod Pathol; 2002 Oct 14; 15(10):1032-7. PubMed ID: 12379748 [Abstract] [Full Text] [Related]
14. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. Scholten AN, Creutzberg CL, van den Broek LJ, Noordijk EM, Smit VT. J Pathol; 2003 Nov 14; 201(3):460-5. PubMed ID: 14595758 [Abstract] [Full Text] [Related]
15. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome. Johnson V, Volikos E, Halford SE, Eftekhar Sadat ET, Popat S, Talbot I, Truninger K, Martin J, Jass J, Houlston R, Atkin W, Tomlinson IP, Silver AR. Gut; 2005 Feb 14; 54(2):264-7. PubMed ID: 15647192 [Abstract] [Full Text] [Related]
17. Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas. Shih HC, Shiozawa T, Miyamoto T, Uchikawa J, Feng Y, Kashima H, Nikaido T, Konishi I. Anticancer Res; 2003 Feb 14; 23(5A):3749-54. PubMed ID: 14666673 [Abstract] [Full Text] [Related]